Intermittent claudication in the patient with diabetes

British Journal of Diabetes and Vascular Disease

Volumn 4, Issue 4, 2004, Pages 238-242

  Jude, Edward B ^a  

^a TAMESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cilostazol; Diabetes; Intermittent claudication; Neuropathy; Peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CILOSTAZOL; CLOPIDOGREL; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; NAFTIDROFURYL; PENTOXIFYLLINE; PHOSPHOLIPASE; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; RAMIPRIL; THROMBOXANE A2;

ANGIOPLASTY; ARTICLE; BEHAVIOR MODIFICATION; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE SEVERITY; EARLY DIAGNOSIS; EXERCISE; GANGRENE; HEALTH CENTER; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; LIMB AMPUTATION; MASS SCREENING; MORBIDITY; PATIENT REFERRAL; PRIMARY MEDICAL CARE; RISK FACTOR; RISK REDUCTION; SYMPTOMATOLOGY; VASCULAR SURGERY;

EID: 4444269490     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514040040040401     Document Type: Article

References (21)

1. Leng GC, Lee AJ, Fowkes FG et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1171-81.
2. Brand FN, Abbot RD, Kannel WB. Diabetes, intermittent claudication and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38: 504-09.
3. Hendra T. New guidelines for antiplatelet agents. Geriatric Medicine 2003;October:89-96.
4. Dormandy JA. Natural history of intermittent claudication. Hospital Update 1991;17:314-20.
5. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31(1 pt 2): S1-S296.
6. Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985;218:27-33.
7. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
8. LoGerfo FW, Gibbons GW. Clinical features and treatment of peripheral vascular disease in diabetes mellitus. In: KGMM Alberti, P Zimmer, RA DeFronzo, H Keen (eds.). International Textbook of Diabetes Mellitus, Second Edition. Chichester: John Wiley & Sons Ltd, 1997.
9. Weitz JI, Byrne J, Clagett GP et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-49.
10. Schmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation and therapeutic strategies. Am J Cardiol 2001;87:3D-13D.
11. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992;45:1101-09.
12. Kannel WB. The demographics of claudication and the ageing American population. Vasc Med 1996;1:60-4.
13. Olin JW. Clinical evaluation and office-based detection of peripheral arterial disease. In: An office-based approach to the diagnosis and treatment of peripheral arterial disease. Am J Med 'Continuing Medical Education Series,' 1998;10-17.
14. Jude EB, Boulton AJM. End stage complications of diabetic neuropathy. Diabetes Reviews 1999;7:395-410.
15. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001;88: 787-800.
16. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. New Engl J Med 2000;342:145-53.
17. Heart Protection Study Collaborative Group. MRC/BHF Heart protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
18. British Medical Association and Royal Pharmaceutical Society of Great Britain, British National Formulary 43. March 2002, BMA and RPSGB, London.
19. Chapman TM, Goa KL. Cilostazol. A review of its use in intermittent claudication. Am J Cardiovas Drugs 2003;3:117-38.
20. Hittel N, Donnelly R. Treating peripheral arterial disease in patients with diabetes. Diabetes Obes Metab 2002;4(suppl 2):S26-S31.
21. Rendell M, Cariski AT, Hittel N, Zhang P. Cilostazol treatment of claudication in diabetic patients. Curr Med Res Opin 2002;18:479-87.